OpenAI recently unveiled a new tool designed specifically for doctors and healthcare professionals. Meanwhile, tech giants like Amazon and Google are advancing these efforts even further, introducing AI-driven solutions to address the shortage of primary care physicians.
Stanford's James Zou, known for his FDA-cleared cardiac AI project EchoNet, is now spearheading a new venture named Human Intelligence. The startup is focused on applying AI technology to advance research on the human body. With cutting-edge achievements including a Virtual Lab that designs novel nanobodies and a Virtual Biotech initiative, Zou is reportedly seeking $100 million in funding at a valuation near $1 billion, according to Bloomberg reports.
A pioneering biotechnology firm has achieved a major breakthrough with a novel gene editing treatment that recently passed its clinical trial phase successfully. The company is now preparing to seek official regulatory approval for this innovative therapy, marking a significant advancement in medical science.
FDA Commissioner announced a groundbreaking shift in clinical trials: regulators will now monitor trial endpoints live via the cloud. This real-time insight promises to make the drug development process faster and more responsive.
Researchers at the Mayo Clinic have created an AI model that can detect early indicators of pancreatic cancer in routine scans, identifying the disease more than a year before traditional diagnosis methods.
A newly released report details notable progress in closing health disparities across various U.S. states from 2022 to 2024. Despite these encouraging developments, experts express concern that the gains may not be maintained long-term without sustained effort and policy support.
RunSafe highlights that the surge in cyberattacks on medical devices is largely driven by the widespread use of outdated technology within healthcare settings. This reliance on legacy systems heightens vulnerabilities, making healthcare environments prime targets for cybercriminals. For additional details, visit the original report on Silicon Republic.
Across sectors like pilot training, healthcare, manufacturing, and immersive entertainment, a new generation of AR and VR companies is successfully transforming extended reality into valuable tools that enhance practical business applications.
AstraZeneca is set to expand its research and development operations in the UK, benefiting from provisions in the latest US-UK trade agreement that aim to boost UK drug spending. This move underscores the positive impact of international trade deals on pharmaceutical investment and innovation in the region.
On Thursday, scientists reported in the journal Science the findings from a study evaluating an OpenAI model's capacity to perform diagnostic and clinical reasoning tasks. The results showcased impressive capabilities, prompting the scientific community to consider the implications and next steps for integrating AI in healthcare diagnostics.
